Non-coding RNA are divided into two main types- infrastructural non coding RNA and regulatory non coding RNA. Non-coding RNA assays are used for quantitative real time PCR analysis of RNA expression.
Non-coding RNA assays consist of a pair of unlabeled PCR primers. A taqman probe with a dye is labelled on the 5’ end and a non-fluorescent quencher, also known as NFQ is present on the 3’ end of the Non-coding RNA assay.
TaqMan non-coding RNA assay is the only available RNA assay in the market, used for the real time PCR of a RNA. Non coding RNA assay is very specific and is easy to use. There are various features of non-coding RNA assay such as accuracy, sensitivity etc. Non-coding RNA assays are very accurate as they identifies the small fold changes with a very high accuracy of quantitation.
To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/30351
Non-coding RNA are ideal for measuring low level of expression. Hence, the positive factors associated with non-coding RNA assays are expected to increase the growth of non-coding RNA assays.
Taqman gene expression is a gold standard in real time PCR for the analysis of gene expression. Each Non coding RNA assay contains target primers and a probe which is sequence specific. In real time PCR, with the help of non-coding RNA assays, there is not any need of optimization, additional designs or melt curve analysis.
Increasing research and developmental activities, is one of the major factor increasing the growth of non-coding RNA assays. Increasing government initiatives and support for the life science research projects, is another important factor which is responsible for the significant growth of non-coding RNA assays. Favorable reimbursement for the life science and biotech research projects, is expected to increase the growth of non-coding RNA assays market.
Various other factors such as increasing number of research institutes and research laboratories, increasing number of people shifting towards higher research studies etc. are expected to increase the growth of non-coding RNA assays market. Availability of different equipment, required for performing research activities, is expected to increase the growth of non-coding RNA assays market.
Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/30351
There are few factors, which can hinder the overall growth of non-coding RNA assays market. High cost of non-coding RNA assays, is expected to hinder the growth of non-coding RNA assays market.
The global Non-coding RNA Assays market is segmented on the basis of Application, End User and geography:
- Segmentation by Application
- Oncological Applications
- Biomarker Development
- Infectious Medicine
- Other Applications
- Segmentation by End User
- Research Laboratories
- Biotechnology Academic Institutes
- Others
Based on the application, the non-coding RNA assays market has been segmented into oncological applications, biomarker development, infectious medicines and other applications. Oncology is expected to hold a significant market share in the non-coding RNA assays market.
Based on end user, the non-coding RNA assays market has been divided into research laboratories, biotechnology academic institutes and other end users. Research laboratories are expected to hold a large revenue share in the non-coding RNA assays market.
Geographically, global non-coding RNA assays market has been segmented into a few key regions i.e. North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa.
North America is expected to dominate the global non-coding RNA assays market due to increasing research and development activities and presence of a large number of research laboratories. Europe is expected to hold a large revenue share in the non-coding RNA assays market due to increasing number of research laboratories.
Asia Pacific is also expected to hold a large revenue share in the non-coding RNA assay, because of the increasing number of people shifting towards research and developmental activities and higher studies.
The non-coding RNA assay market is not a segmented market. The company has a monopoly in the non-coding RNA assays market. Taqman non- coding RNA assay is the only non-coding RNA assay, manufactured by Thermo Fisher Scientific Inc.
For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/30351
The report covers exhaustive analysis on:
- Non-coding RNA Assays Market Segments
- Non-coding RNA Assays Market Dynamics
- Historical Actual Market Size, 2013 – 2015
- Non-coding RNA Assays Market Size & Forecast 2016 to 2024
- Non-coding RNA Assays Agents Current Trends/Issues/Challenges
- Competition & Companies involved
- Non-coding RNA Assays Market Drivers and Restraints
Regional analysis includes
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Report Highlights:
- Shifting Industry dynamics
- In-depth Non-coding RNA Assays market segmentation
- Historical, current and projected industry size Recent industry trends
- Key Competition landscape
- Strategies for key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance